Mar 29, 2011 - Category: BayBio Event
|
Bayer HealthCare, one of the top 10 diversified healthcare companies, is actively seeking collaborative drug discovery partnerships with U.S. life sciences firms and research institutions to advance new medicines to patients. Bayer Partnering Day is an exclusive event that is designed to connect companies with high quality therapeutic and technology projects with Bayer for potential collaboration discussions.
|
Partnering Areas of Interest
Oncology • Cardiology • Gynecology • Diagnostic Imaging
|

Why Partner with Bayer HealthCare?
Bayer HealthCare has a long and successful track record in advancing partnered projects from the research bench to patients and physicians around the world. With sales greater than €10 Billion in 2009, Bayer is the 12th largest global pharmaceutical company, and among the top 10 biotechnology firms.
Bayer’s strong commitment to collaboration is evidenced by the fact that one third of Bayer’s research and development portfolio is collaborative projects. Leading marketed products such as Nexavar® demonstrate Bayer’s ability to bring scientific, clinical development and global commercial expertise to any project. The company seeks to work with life science firms who have made novel discoveries by bringing the depth of Bayer’s technical expertise in core scientific and therapeutic areas to partnered projects. Examples of our collaborations include our work with OncoMed to explore novel anti-cancer stem cell therapeutics targeting the Wnt signaling pathway and with Regeneron to develop Eylea® for the treatment of eye disease.
|
What: |
Bayer Partnering Day |
|
When: |
Tuesday, March 29, 2011
8:00am – 10:00am: Breakfast Plenary
10:00m – 4:30pm: One-on-One Partnering Meetings
4:30pm – 6:30pm: Closing Reception |
|
Where: |
BayBio
400 Oyster Point Blvd., Suite 221
South San Francisco, CA 94080
View Map and driving directions |
|
Admission: |
Participation is Open to
Pre-Qualified Life Science Companies

Please e-mail completed application to misha@baybio.org
BayBio Members | Free
Non-Members | $500*
*Event registration fees can be applied toward first year's membership if company joins within 30 days of partnering event. |
|
Attire: |
Business attire suggested |
|
 |
Please contact Misha Tsirulnikov at misha@baybio.org or 650-871-7101 x205 for further information.
Is your company a member? Click here to check.
See how your company can save money by becoming a BayBio member!
Oncology
Anti-angiogenic, anti-tumor and selective anti-proliferative therapies for solid tumors.
Cardiology
Novel approaches to the care of chronic and/or acute pulmonary hypertension, atrial fibrillation, heart failure, acute coronary syndrome, ischemic stroke, peripheral arterial occlusive disease, disseminated intravascular coagulation, acute lung injury/adult respiratory distress syndrome, and cardioprotection.
Gynecology
Novel treatment options for endometriosis (adenomyosis uteri/endometriosis interna) and uterine fibroids (uterine leiomyoma) and abnormal uterine bleeding (heavy menstrual bleeding, breakthrough bleeding).
Diagnostic Imaging
Oncology (early diagnosis and staging, early therapy response, predictive stratification of patients) and CNS (Alzheimer's disease, other forms of dementia, neuroinflammation), using positron emission tomography (PET) as modality.
Start Date: Mar 29, 2011. 08:00 AM
End Date: Mar 29, 2011. 06:30 PM
Location: BayBio
Address: 400 Oyster Point Blvd, Suite 221, South San Francisco, CA, 94080
Cost: BayBio Members | Free
Non-Members | $500*